A Study Evaluating the Pharmacokinetics and Relative Bioavailability of Emraclidine Immediate-Release Tablets in Healthy Adult Participants
Clinical trial NCT05933187 · COMPLETED
Trial details
- NCT number
- NCT05933187
- Sponsor
- Cerevel Therapeutics, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-19
- Primary completion
- 2023-09-12
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.